Effect of NADPH-oxidase inhibitors in the experimental model of zymosan-induced shock in mice

References

• Shayevitz JR, Miller C, Johnson KJ, Rodriguez JL. Multiple organ dysfunction syndrome: end organ and systemic inflammatory response in a mouse model of nonseptic origin. Shock 1995;4:389–396.
   PubMed Web of Science ®Google Scholar
• Volman TJ, Hendriks T, Goris RJ. Zymosan-induced generalized inflammation: experimental studies into mechanisms leading to multiple organ dysfunction syndrome. Shock 2005; 23:291–297.
   PubMed Web of Science ®Google Scholar
• Petit F, Bagby GJ, Lang CH. Tumor necrosis factor mediates zymosan-induced increase in glucose flux and insulin resistance. Am J Physiol 1995;268:219–228.
   Google Scholar
• Cuzzocrea S, de Sarro G, Costantino G, Mazzon E, Laura R, Ciriaco E, . Role of interleukin-6 in a non-septic shock model induced by zymosan. Eur Cytokine Netw 1999;10: 191–203.
   PubMed Web of Science ®Google Scholar
• Ward PA, Till GO, Kunkel R, Beauchamp C. Evidence for role of hydroxyl radical in complement and neutrophil-dependent tissue injury. J Clin Invest 1983;72:789–801.
   PubMed Web of Science ®Google Scholar
• Dodd OJ, Pearse DB. Effect of the NADPH oxidase inhibitor apocynin on ischemia-reperfusion lung injury. Am J Physiol Heart Circ Physiol 2000;279:303–312.
   PubMed Web of Science ®Google Scholar
• Babior BM. The respiratory burst oxidase. Curr Opin Hematol 1995;2:55–60.
   PubMedGoogle Scholar
• Weiss SJ. Tissue destruction by neutrophils. New Engl J Med 1989;320:365–376.
   PubMed Web of Science ®Google Scholar
• Hougee S, Hartog A, Sanders A, Graus YM, Hoijer MA, Garssen J, . Oral administration of the NADPH-oxidase inhibitor apocynin partially restores diminished cartilage proteoglycan synthesis and reduces inflammation in mice. Eur J Pharmacol 2006;531:264–269.
   PubMed Web of Science ®Google Scholar
• Johnson DK, Schillinger KJ, Kwait DM, Hughes CV, McNamara EJ, Ishmael F, . Inhibition of NADPH oxidase activation in endothelial cells by ortho-methoxy-substituted catechols. Endothelium 2002;9:191–203.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Chan MM, Andrews MC, Mori TA, Croft KD, McKenzie KU, . Apocynin but not allopurinol prevents and reverses adrenocorticotropic hormone-induced hypertension in the rat. Am J Hypertens 2005;18:910–916.
   PubMed Web of Science ®Google Scholar
• Dodd-o JM, Welsh LE, Salazar JD, Walinsky PL, Peck EA, Shake JG, . Effect of NADPH oxidase inhibition on cardiopulmonary bypass-induced lung injury. Am J Physiol Heart Circ Physiol 2004;287:927–936.
   Web of Science ®Google Scholar
• Beukelman CJ, Van den Berg AJ, Kroes BH, Labadie RP, Mattsson EE, Van Dijk H. Plant-derived metabolites with synergistic antioxidant activity. Immunol Today 1995;16:108.
   PubMedGoogle Scholar
• Stolk J, Hiltermann TJ, Dijkman JH, Verhoeven AJ. Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol. Am J Resp Cell Mole Biol 1994;11:95–102.
   PubMed Web of Science ®Google Scholar
• Cheret C, Gervais A, Lelli A, Colin C, Amar L, Ravassard P, . Neurotoxic activation of microglia is promoted by a nox1-dependent NADPH oxidase. J Neurosci 2008;28:12039–12051.
   PubMed Web of Science ®Google Scholar
• Harrigan TJ, Abdullaev IF, Jourd'heuil D, Mongin AA. Activation of microglia with zymosan promotes excitatory amino acid release via volume-regulated anion channels: the role of NADPH oxidases. J Neurochem 2008;106: 2449–2462.
   PubMed Web of Science ®Google Scholar
• Mendes AF, Carvalho AP, Caramona MM, Lopes MC. Diphenyleneiodonium inhibits NF-kappaB activation and iNOS expression induced by IL-1beta: involvement of reactive oxygen species. Mediators Inflamm 2001;10:209–215.
   PubMed Web of Science ®Google Scholar
• Abdelrahman M, Mazzon E, Bauer M, Bauer I, Delbosc S, Cristol JP, . Inhibitors of NADPH oxidase reduce the organ injury in hemorrhagic shock. Shock 2005;23:107–114.
   PubMedGoogle Scholar
• Ferrer TJ, Webb JW, Wallace BH, Bridges CD, Palmer HE, Robertson RD, Cone JB, Interleukin-10 reduces morbidity and mortality in murine multiple organ dysfunction syndrome (MODS). J Surg Res 1998;77:157–164.
   PubMed Web of Science ®Google Scholar
• Kono H, Rusyn I, Uesugi T, Yamashina S, Connor HD, Dikalova A, . Diphenyleneiodonium sulfate, an NADPH oxidase inhibitor, prevents early alcohol-induced liver injury in the rat. Am J Physiol 2001;280:1005–1012.
   Google Scholar
• Impellizzeri D, Mazzon E, Esposito E, Paterniti I, Bramanti P, Cuzzocrea S. Effect of Apocynin, an inhibitor of NADPH oxidase, in the inflammatory process induced by an experimental model of spinal cord injury. Free Radic Res 2011;45: 221–236.
   PubMed Web of Science ®Google Scholar
• Deng X, Wang X, Andersson R. Alterations in endothelial barrier permeability in multiple organs during overactivation of macrophages in rats. Shock 1996;6:126–133.
   PubMed Web of Science ®Google Scholar
• Cuzzocrea S, Mazzon E, Di Paola R, Patel NS, Genovese T, Muia C, . Erythropoietin reduces the development of experimental inflammatory bowel disease. J Pharmacol Exp Ther 2004;311:1272–1280.
   PubMed Web of Science ®Google Scholar
• Abdelrahman M, Sharples EJ, McDonald MC, Collin M, Patel NS, Yaqoob MM, Thiemermann C. Erythropoietin attenuates the tissue injury associated with hemorrhagic shock and myocardial ischemia. Shock 2004;22:63–69.
   PubMed Web of Science ®Google Scholar
• Cuzzocrea S, Rossi A, Serraino I, Di Paola R, Dugo L, Genovese T, . Role of 5-lipoxygenase in the multiple organ failure induced by zymosan. Intens Care Med 2004;30: 1935–1943.
   PubMed Web of Science ®Google Scholar
• Mahesh J, Daly J, Cheadle WG, Kotwal GJ. Elucidation of the early events contributing to zymosan-induced multiple organ dysfunction syndrome using MIP-1alpha, C3 knockout, and C5-deficient mice. Shock 1999;12:340–349.
   PubMed Web of Science ®Google Scholar
• Bowie A, O'Neill LA. Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries. Biochem Pharmacol 2000;59:13–23.
   PubMed Web of Science ®Google Scholar
• Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. New Engl J Med 1997;336:1066–1071.
   PubMed Web of Science ®Google Scholar
• Crofford LJ, Tan B, McCarthy CJ, Hla T. Involvement of nuclear factor kappa B in the regulation of cyclooxygenase-2 expression by interleukin-1 in rheumatoid synoviocytes. Arthritis Rheum 1997;40:226–236.
   PubMed Web of Science ®Google Scholar
• Volman TJ, Hendriks T, Verhofstad AA, Kullberg BJ, Goris RJ. Improved survival of TNF-deficient mice during the zymosan-induced multiple organ dysfunction syndrome. Shock 2002; 17:468–472.
   PubMed Web of Science ®Google Scholar
• Ley K, Laudanna C, Cybulsky MI, Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nature Rev 2007;7:678–689.
   Web of Science ®Google Scholar
• Rupin A, Paysant J, Sansilvestri-Morel P, Lembrez N, Lacoste JM, Cordi A, Verbeuren TJ. Role of NADPH oxidase-mediated superoxide production in the regulation of E-selectin expression by endothelial cells subjected to anoxia/reoxygenation. Cardiovasc Res 2004;63:323–330.
   PubMed Web of Science ®Google Scholar
• Cuzzocrea S, Zingarelli B, Sautebin L, Rizzo A, Crisafulli C, Campo GM, . Multiple organ failure following zymosan-induced peritonitis is mediated by nitric oxide. Shock 1997;8: 268–275.
   PubMed Web of Science ®Google Scholar
• Di Paola R, Esposito E, Mazzon E, Genovese T, Muia C, Crisafulli C, . Absence of peroxisome proliferators-activated receptors (PPAR)alpha enhanced the multiple organ failure induced by zymosan. Shock 2006;26:477–484.
   PubMedGoogle Scholar
• Cuzzocrea S, Rossi A, Pisano B, Di Paola R, Genovese T, Patel NS, . Pyrrolidine dithiocarbamate attenuates the development of organ failure induced by zymosan in mice. Intens Care Med 2003;29:2016–2025.
   PubMed Web of Science ®Google Scholar
• Herrera B, Alvarez AM, Sanchez A, Fernandez M, Roncero C, Benito M, Fabregat I, Reactive oxygen species (ROS) mediates the mitochondrial-dependent apoptosis induced by transforming growth factor (beta) in fetal hepatocytes. Faseb J 2001;15:741–751.
   PubMed Web of Science ®Google Scholar
• Peng Y, Gallagher SF, Haines K, Baksh K, Murr MM. Nuclear factor-kappaB mediates Kupffer cell apoptosis through transcriptional activation of Fas/FasL. J Surg Res 2006;130: 58–65.
   PubMed Web of Science ®Google Scholar
• Hohlbaum AM, Gregory MS, Ju ST, Marshak-Rothstein A. Fas ligand engagement of resident peritoneal macrophages in vivo induces apoptosis and the production of neutrophil chemotactic factors. J Immunol 2001;167:6217–6224.
   PubMed Web of Science ®Google Scholar
• Dong J, Sulik KK, Chen SY. The role of NOX enzymes in ethanol-induced oxidative stress and apoptosis in mouse embryos. Toxicol Lett 2010;193:94–100.
   PubMed Web of Science ®Google Scholar